Cardinal Health, Inc. (CAH)
$
154.19
-0.12 (-0.08%)
Key metrics
Financial statements
Free cash flow per share
7.7406
Market cap
37.7 Billion
Price to sales ratio
0.1694
Debt to equity
-3.0662
Current ratio
0.9351
Income quality
1.5277
Average inventory
16.5 Billion
ROE
-0.5205
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Cardinal Health, Inc. operates as an integrated healthcare services and products company providing customized solutions across the United States, Canada, Europe, Asia, and other international markets. The company offers tailored services to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home care patients. The company functions in two primary segments: Pharmaceutical and Medical. The Pharmaceutical segment is responsible for distributing both branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products. Additionally, it supports pharmaceutical manufacturers and healthcare providers through various services linked to specialty pharmaceuticals; manages nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic and over-the-counter healthcare products; and delivers medication therapy management and patient outcomes services to hospitals, healthcare providers, and payers. The operational income ratio is 0.01 indicating the company's operational profitability margin, while the company recorded an operating income of $2,275,000,000.00 reflecting its earnings from core operations. The income before tax ratio stands at 0.01 which shows the pre-tax margin. On the stock market, the company’s stock is identified with the symbol 'CAH', and the gross profit is $8,168,000,000.00 highlighting the company's profitability from its core operations. Conversely, the Medical segment involves the manufacture, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products, along with a comprehensive range of solutions for healthcare providers. The stock is reasonably priced at $149.60 appealing to a broad array of investors. With a high average trading volume of 2,344,662.00 it demonstrates strong liquidity in the market. The company boasts a mid-range market capitalization of $36,820,072,733.00 positioning it as a steady performer within the industry. As a key player in the Medical - Distribution industry, Cardinal Health significantly contributes to the overall market landscape and embraces its role in driving innovation and growth as part of the Healthcare sector. The combination of a robust product portfolio, strategic market presence, and solid financial metrics underlines the company's commitment to delivering effective healthcare solutions.
Investing in Cardinal Health, Inc. (CAH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Cardinal Health, Inc. stock to fluctuate between $106.98 (low) and $168.44 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-10-14, Cardinal Health, Inc.'s market cap is $36,820,072,733, based on 238,796,762 outstanding shares.
Compared to Eli Lilly & Co., Cardinal Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
Cardinal Health, Inc. pays dividends. The current dividend yield is 1.29%, with a payout of $0.51 per share.
To buy Cardinal Health, Inc. (CAH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAH. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Cardinal Health, Inc.'s last stock split was 3:2 on 2001-04-23.
Revenue: $222,578,000,000 | EPS: $6.48 | Growth: 86.21%.
Visit https://www.cardinalhealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $168.44 (2025-07-01) | All-time low: $45.85 (2021-12-01).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
The latest trading day saw Cardinal Health (CAH) settling at $154.31, representing a -1.64% change from its previous close.
zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
zacks.com
Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zacks.com
The latest trading day saw Cardinal Health (CAH) settling at $154.46, representing a -2.52% change from its previous close.
zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
wsj.com
The planned 230,000 square-foot plant is the healthcare company's latest step in a 10-year plan to modernize and expand its distribution network.
prnewswire.com
DUBLIN, Ohio , Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network.
zacks.com
Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
See all news